Feb 06, 2016 at 15:23 | Source: PTI
AstraZeneca Q3 net profit at Rs 8.67 cr New Delhi, Feb 6 (PTI) Drug firm AstraZeneca Pharma India today reported a standalone net profit of Rs 8.67 crore for the third quarter ended December 31.
Feb 06, 2016 at 11:30 | Source: Moneycontrol.com
Aarti Drugs has reported a consolidated total income from operations of Rs 268.67 crore and a net profit of Rs 17.03 crore for the quarter ended Dec '15
Feb 05, 2016 at 20:55 | Source: CNBC-TV18
Kiran Mazumdar Shaw, CMD, Biocon, calls this to be an irrational commentary from the governments side, as it will only the end-userthe patientwho will have to pay the increased cost.
Feb 05, 2016 at 18:22 | Source: PTI
Drug firm Dishman Pharmaceuticalsand Chemicals today reported a nearly two-fold jump inconsolidated net profit to Rs 46.93 crore for the quarterended December 31.
Feb 05, 2016 at 17:44 | Source: Moneycontrol.com
BofA ML, in a report titled Media news: US making API mfg mandatory locally for Govt. supplies; minimal impact, says that while the main motive behind the move is to promote API industry, it could directly impact the core companies in the field and could also face implementation headwinds.
Feb 05, 2016 at 17:36 | Source: CNBC-TV18
Sources tell CNBC-TV18 that customs duty ranging from 16 to 20 percent will be imposed on the drugs
Feb 05, 2016 at 15:16 | Source: Moneycontrol.com
Aarti Drugs Ltd has informed BSE that the Board of Directors of the Company at its meeting held on February 05, 2016, has declared 2nd Interim Dividend at Rs 1.50 (15 percent) per share for the financial year 2015-2016.
Feb 05, 2016 at 10:30 | Source: CNBC-TV18
The US governments decision to not allow overseas pharmaceutical companies to import active pharmaceutical ingredient (API) applies to only one particular anti retroviral drug and is not a blanket ban, Biocon CMD Kiran Mazumdar-Shaw said.
Feb 04, 2016 at 21:56 | Source: PTI
The company had posted a net profit of Rs 92.5 crore for the corresponding period of the previous fiscal, Sanofi India said in a BSE filing.
Feb 04, 2016 at 21:54 | Source: Reuters
Shkreli, 32, sparked outrage last year among patients, medical societies and Democratic presidential front-runner Hillary Clinton after Turing raised the price of 62-year-old Daraprim to USD 750 a pill from USD 13.50